Paul Cataford, Titan Medical Inc.’s interim president and CEO, said he is laser-focused on getting U.S. Food and Drug Administration clearance for Enos, the company’s single-access robotic surgical system. The goal is to offer it for general gynecological procedures by early 2025, he said, with the qualifier that the company still has to go through a lot […]

SEATTLE — Patients with ALS who were treated with CNM-Au8 — a gold nanocrystal suspension — showed improvements in survival, a speaker said at the 2022 American Academy of Neurology annual meeting. “This is a phase 2 study and needs a larger phase 3 confirmatory, international clinical trial,” Matthew Kiernan, PhD, DSc, the Bushell Chair of […]

NeuroSense Therapeutics has enrolled and dosed the first healthy subject in the pharmacokinetic (PK) study of its combination drug candidate, PrimeC, to treat amyotrophic lateral sclerosis (ALS). PrimeC comprises a fixed-dose mixture of ciprofloxacin and celecoxib, which are approved by the US Food and Drug Administration (FDA).